The (3-globin locus control region (LCR) is characterized by erythroid-speciflc DNase I hypersensitive sites and is involved in the chromatin organization, trancriptional potentiation, developmental regulation, and replication tming of the entire (-globin gene duster. When and how the LCR is first activated during erythropoiesis is not known. Here we analyze the chromatin structure of the LCR during early hematopoietic differentiation using nontransformed, multipotential, growth factor-dependent, murine hematopoietic progenitor cells. We show that LCR hypersensitive sites characteristic of erythroid cells are present in three independent multilineage progenitors (FDCP (factor-dependent cell, Paterson)-mix A4, B6SUtA, and LyD9] under conditions of selfrenewal. Induction of differentiation down a nonerythroid pathway causes a progressive loss of hypersensitivity in the LCR. These results show that the (3-globin LCR is in an active chromatin configuration prior to erythroid commitment and indicate a significant role for selective gene repression in lineage specification.
The significance of this region was highlighted with the discovery of naturally occurring deletions in man that remove the LCR and render the remaining globin genes (in cis) inactive (4) (5) (6) (7) (8) . Molecular analysis has revealed the following properties of the LCR: (i) the LCR confers high-level erythroid-specific expression on cis-linked genes in transgenic mice, the level of expression depending on the copy number and not on the site of integration (9) (10) (11) (12) ; (ii) the LCR affects both the chromatin structure and pattern of DNA replication of sequences extending over 200 kilobases (kb) downstream of the LCR (8) ; (iii) the interaction between individual globin genes and the LCR is mutually exclusive and developmentally regulated (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) ; (iv) the regulatory elements responsible for LCR function are contained within the nucleasehypersensitive sites that characterize the LCR in erythroid cells (23) (24) (25) (26) (27) ; and (v) the structure and function of the LCR have been highly conserved during evolution (refs. 28-30; T.E., unpublished data). These collective properties of the LCR suggest that it is not simply an enhancer in the classical sense but represents a new type ofgenetic regulatory element (see refs. 31 and 32 for review).
Little is known about the relationship between processes controlling the activation of the LCR and those involved in the specification of the erythroid lineage. One approach to this issue is through the analysis of multipotential hematopoietic stem cells that retain erythroid differentiation potential. Unfortunately, these cells are rare in vivo and difficult to isolate in the number or purity required to perform molecular studies (33) (34) (35) . While transformed cell lines have therefore served as a model for the molecular analysis of the stem cell compartment (36, 37) , these cells are for the most part unresponsive to hematopoietic growth factors as well as other normal regulatory signals. However, nontransformed, multipotential, hematopoietic cell lines have been established from long-term cultures ofadult mouse bone marrow (38) (39) (40) . These cells are not immortalized, possess normal karyotypes, and are not leukemic in vivo. They are maintained as self-renewing, undifferentiated cells by the hematopoietic growth factor interleukin 3 (IL-3) and are able to differentiate in response to physiological signals such as granulocyte/ macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), and erythropoietin. On the basis of such biological properties, these cell lines offer a unique model for the molecular analysis of early hematopoietic differentiation. We DNase I Analysis. Cells (1-5 x 107) were used for each DNase I series, which was prepared essentially as described (44) . Briefly, cells were washed repeatedly with cold phosphate-buffered saline, then lysed in ice-cold isolation buffer (60 mM KCI/15 mM NaCl/5 mM MgCl2/15 mM Tris-HCl, pH 7.4/0.3 M sucrose/0.5 mM dithiothreitol/0.1 mM phenylmethylsulfonyl fluoride/0.1 mM EDTA) by addition of Nonidet P-40 to 0.2%. Nuclei were separated from cytoplasmic debris by centrifugation through a sucrose cushion (isolation buffer containing 1.7 M sucrose) for 15 min at 1000 x g. Purified nuclei were resuspended in ice-cold isolation buffer containing 5% (vol/vol) glycerol at =3 x 107 per ml, and aliquots were digested with differing concentrations of DNase I (0-6 pAg/ml) for 3 min at room temperature. Reactions were terminated by addition of SDS and EDTA to final concentrations of 0.5% and 10 mM, respectively. Samples were digested with proteinase K (100 lg/ml) at 37°C overnight, and DNA was isolated by repeated organic extraction and ethanol precipitation. Purified DNA was limit-restricted and subjected to conventional Southern blot analysis (45).
Probes. 3-globin LCR. Two probes were used in this study (probes x and y in Fig. 1A ). Both probes (designed on the basis of DNA sequence information presented in ref. 46 ) were synthesized by PCR with the following primers: probe x, 5'-CCCAGAAGAAGAAAAACACCAG-3' and 5'-CCTCT-TCAGCATTTAGTGTCC-3'; probe y, 5'-CTAGCTAAGAA-AGACATGGC-3' and 5'-CTGCAGGAAGCCCTAAACC-3'.
Immunoglobulin heavy chain gene (Igh) enhancer. A 1.9-kb BamHI-EcoRI fragment from the murine Igh joining region JH (47) .
CD38 gene enhancer. A 0.7-kb EcoRI-Xba I intron fragment from the murine CD36 gene (48) .
RESULTS AND DISCUSSION
Erythroid Cells. Sequences homologous to two human LCR hypersensitive sites-namely, 5' HS1 and 5' HS2-have recently been cloned from the mouse and shown to be hypersensitive in murine erythroleukemia (MEL) cells (refs. 29 and 46; T.E., unpublished data). This region is polymorphic in the mouse (G.J. and T.E., unpublished observations), and a simplified map showing the position of 5' HS1 and 5' HS2 in the two alleles so far identified (alleles a and b) is shown in Fig. 1A . The polymorphism results in a change in the spacing between 5' HS1 and 5' HS2, which complicates DNase I analysis. Thus, when using the probe and restriction digest combinations shown in Fig. 1A , 5' HS1 is detected as a 3.6-kb subband regardless of the parental allele, whereas the size of the subband corresponding to 5' HS2 depends on the allele from which it is derived; the subband from allele a (designated 5' HS2a) is 7.4 kb, and the subband from allele b (designated 5' HS2b) is 5.5 kb. To characterize 5' HS1 and 5' HS2 in normal erythroid cells, we analyzed day 14 fetal liver, which at this stage of development is the major site of definitive erythropoiesis and is composed predominantly of nucleated erythroid cells (49) . Homozygous b/b females (C57BL/6J) were mated with heterozygous a/b males (B6D2F1) to obtain embryos at day 14 of gestation. Fetal liver tissue from several different embryos was pooled for DNase I analysis. DNA from DNase I-treated nuclei was digested with Pst I and analyzed by Southern blotting. The results of this analysis (Fig. 1B) show clearly that both 5' HS1 and 5' HS2 are present in these normal erythroid cells. Note that the relative intensity of the subbands corresponding to 5' HS2a and 5' HS2b is a consequence of the differential representation of the a and b alleles in the pooled fetal liver samples analyzed.
Lymphoid Cells. We next examined the chromatin structure of the LCR in normal mouse lymphocytes. Since spleen is a convenient source of mature B and T lymphocytes, we prepared spleen cells from adult B6D2F1 mice. Immunophenotypic analysis showed that the ratio of B to T lymphocytes in these preparations was -2:1 (not shown). DNase I analysis of these cells failed to reveal the presence of hypersensitive sites in the 3-globin LCR (Fig. 2A) . We also analyzed thymic lymphoid cells isolated from 3-week-old B6D2F1 mice (Fig.  3A) . Immunophenotyping demonstrated that the thymus samples were composed almost exclusively (98%) of T lymphocytes, most of which appeared to be immature (not shown). These thymocytes also lacked nuclease hypersensitive sites in the LCR. In neither case was the inability to detect LCR hypersensitive sites due to a technical failure in the DNase I analysis, since control experiments analyzing immunoglobulin heavy chain and CD38 enhancer hypersensitive sites (48, 50) demonstrated the technical quality ofboth spleen (Fig. 2B ) and thymocyte (Fig. 3B) series. The absence of 5' HS1 and 5' HS2 in normal mouse lymphocytes is in agreement with previous results obtained from normal nonerythroid hematopoietic cells in human (3). However, it is noteworthy that the "alternative" hypersensitive sites characteristic of the human 3-globin LCR in normal nonerythroid hematopoietic cells (6) are also absent from normal mouse lymphocytes. The significance of this species difference is unclear since the function of these "alternative sites" is currently not understood. Multipotential Cells. When are the DNase I hypersensitive sites present in erythroid cells established? Is it before, con- comitant with, or after erythroid commitment? To address this question we analyzed the chromatin structure of the P-globin LCR in multipotential progenitor cells. We first examined the multimyeloid progenitor FDCP-mix A4 (38) . The differentiative range of these cells includes macrophages, granulocytes, megakaryocytes, mast cells, erythrocytes, and osteoclasts; both 5' HS1 and 5' HS2 are present in these cells (Fig. 4A) . We next analyzed B6SUtA cells, another factor-dependent multimyeloid cell line with demonstrable macrophage, neutrophil, basophil, and erythroid differentiation capacity (39, 41) . The results of this analysis are presented in Fig. 4B and show that both 5' HS1 and 5' H-S2 are present in these cells. Similar results were obtained with a third factor-dependent cell line, LyD9 (Fig. 4C) . In addition to multimyeloid lineage potential, LyD9 cells have been reported to exhibit B-lymphocyte differentiation, albeit at low frequency (40, 51) . Taken together, these results suggest that 5' HS1 and 5' HS2 are already established in multimyeloid progenitor cells before a decision to commit exclusively to the erythroid lineage has been taken. Furthermore, the results obtained from LyD9 cells raise the possibility that the formation of 5' HS1 and 5' HS2 is not simply a function ofgeneralized myeloid commitment but also is a feature of cells that retain both lymphoid and myeloid differentiation potentials. The results are consistent with a model in which selfrenewing, multipotential, hematopoietic stem cells initiate a program of (8-globin LCR activation that is maintained upon differentiation down the erythroid pathway but interrupted upon differentiation to alternative nonerythroid lineages. We explored this possibility further by culturing FDCP-mix A4, LyD9, and B6SUtA cells in suspension in the presence of G-CSF and GM-CSF. Differentiation was monitored at various times after induction by immunophenotypic, enzymatic, and morphological analyses. In the case of the B6SUtA and LyD9 cells, only 20-30% of the induced population represented nonerythroid myeloid cells, the remainder being undifferentiated blasts. The efficiency of differentiation of multipotential cells in suspension culture is highly dependent on culture conditions vis-A-vis the balance of given hematopoietic growth factors, and conditions for optimizing myeloid differentiation of B6SUtA and LyD9 cells to a level that is useful for DNase I analysis have not yet been defined. For FDCP-mix A4 cells however, induced populations containing up to 95% of immature and mature granulocytes and macrophages can be obtained. A DNase I analysis of G-/GM-CSFinduced FDCP-mix A4 cells is presented in Fig. SA and shows that while hypersensitivity is retained in the region of 5' HS2, it is clearly lost at 5' HS1. The chromatin structure of the LCR in G-/GM-CSF-induced FDCP-mix A4 cells was compared to that of more mature myeloid cells isolated from the peritoneal cavity of adult mice (immunophenotypic and morphological analysis showed that -80%o of these cells were myeloid, the remaining 20%6 being mainly B lymphocytes; data not shown). These results are presented in Fig. 5B and again show the loss of 5' HS1 and the retention of 5' HS2. However, with the caveat that these hypersensitive site analyses are more qualitative than quantitative, the subband corresponding to 5' HS2 in this and other series of peritoneal myeloid cells (not shown) appears to be quite weak. We interpret this faint subband as indicative either (i) that 5' HS2 has a diminished sensitivity in these cells or, in our view more likely, (ii) that the cells we have analyzed are still somewhat heterogeneous in terms of their differentiation and only a subpopulation of them (perhaps the more immature) retains 5' HS2. In such a scheme, differentiation to a nonerythroid myeloid lineage is accompanied by the loss first of 5' HS1 followed by the loss of 5' HS2, day 5 myeloid-induced The temporal uncoupling of hypersensitivity at 5' HS1 and 5' HS2 during myeloid differentiation is intriguing. The results imply two things. First, the mechanisms underlying hypersensitivity at 5' HS1 and 5' HS2 must be independent. Second, the mechanisms responsible for hypersensitivity at 5' HS1 are more tightly associated with erythroid potential than those involved in hypersensitivity at 5' HS2. The delayed closing of 5' HS2 may reflect the fact that 5' HS2 has potential binding sites for a number of ubiquitous transcription factors (25, 26) ; deregulated binding of these factors could explain the formation of 5' HS2 in certain transformed cell lines lacking erythroid potential (ref. 52; G.J. and T.E., unpublished data). In addition to these structural differences between 5' HS1 and 5' HS2, functional differences between 5' HS1 and 5' HS2 have also been reported. Thus, while gene transfer experiments have shown that 5' HS2 can confer high-level erythroidspecific expression on cis-linked genes, they have failed to reveal a transcriptional activation role for 5' HS1 (11, 25, 53, 54) . However, the fact that 5' HS1 has been highly conserved during evolution (30) , together with our finding that hypersensitivity at this site is tightly linked with erythroid differentiation potential, suggests that 5' HS1 is a significant component of LCR function. These results further emphasize the complexity of the LCR, different LCR sites being controlled by different processes and presumably serving different functions. In this regard it will be ofinterest to know the chromatin status ofthe murine homologues of human /3-globin LCR sites 3 and 4 in these self-renewing and lineage-committed populations of factor-dependent multipotential cells. We have recently isolated phage A clones spanning this region of the mouse f3-globin LCR (G.J. and T.E., unpublished data) and are in the process of characterizing them.
Perspective. Our results on the chromatin structure of the ,8-globin LCR in normal multipotential and lineagecommitted hematopoietic cells are modeled in Fig. 6 . In this scenario, the program of f-globin activation is set in motion prior to erythroid commitment, as evidenced by the accessibility of 8- Genetics: Jimdnez et A Proc. Natl. Acad. Sci. USA 89 (1992) way. These data support the notion (36, 55) that some degree of lineage promiscuity exists in multipotential hematopoietic cells and that unifineage commitment and differentiation involves not only consolidation of the activity of "appropriate" genes but also repression of other "primed" genes that are now out of context for the lineage program. Gene repression models have also been proposed for the control of cell specification during ontogeny (56) . In support of such models are recent data suggesting that the gene for the MyoD transcription factor is active in embryonic Caenorhabditis elegans and Xenopus cells that are not yet restricted to muscle differentiation (57) .
Finally, multipotential hematopoietic cells including FDCP-mix A4 have recently been found to have at least low-level expression of GATA-1 (58, 59) , an essential erythroid lineage transcription factor (refs. 60-62; reviewed in ref. 31) for which there are recognition sites in the f3-globin LCR (reviewed in ref. 31) . Therefore, these cells, which have initiated but presumably not completed a program of f-globin locus activation, may offer a unique opportunity both to unravel the molecular complexities of LCR function and to determine the critical or rate-limited events in erythroid commitment and differentiation.
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